Table 3 Frequency of symptoms between two groups in three measurement status
Variable | Group | Start time N (%) | 3rd month N (%) | 9th month N (%) |
|---|---|---|---|---|
Fibrillation | Drug | |||
0 | 18 (100) | 7 (38.9) | 16 (88.9) | |
1+ | 0 (0) | 2 (11.1) | 0 (0) | |
2+ | 0 (0) | 7 (38.9) | 2 (11.1) | |
3+ | 0 (0) | 7 (11.1) | 0 (0) | |
Placebo | ||||
0 | 18 (100) | 6 (33.3) | 14 (77.8) | |
1+ | 0 (0) | 3 (16.7) | 2 (11.1) | |
2+ | 0 (0) | 6 (33.3) | 2 (11.1) | |
3+ | 0 (0) | 3 (16.7) | 0 (0) | |
Numbness | Drug | 0 (0) | 12 (66.7) | 2 (11.1) |
Placebo | 0 (0) | 12 (66.7) | 4 (22.2) | |
Tingling | Drug | 0 (0) | 18 (100) | 11 (61.1) |
Placebo | 0 (0) | 18 (100) | 12 (66.7) | |
Freezing | Drug | 0 (0) | 12 (66.7) | 10 (55.6) |
Placebo | 0 (0) | 12 (66.7) | 10 (55.6) | |
Sensitivity to touch | Drug | 0 (0) | 2 (11.1) | 0 (0) |
Placebo | 0 (0) | 6 (33.3) | 0 (0) | |
Muscle weakness | Drug | 0 (0) | 1 (5.6) | 0 (0) |
Placebo | 0 (0) | 1 (5.6) | 0 (0) | |
Elbow reflex | Drug | 18 (100) | 17 (94.4) | 17 (94.4) |
Placebo | 18 (100) | 14 (77.8) | 18 (100) | |
Knee reflex | Drug | 18 (100) | 16 (88.9) | 18 (100) |
Placebo | 18 (100) | 15 (83.3) | 17 (94.4) |